SHARE
COPY LINK

HEALTH

WHO expects more monkeypox-related deaths in Europe

The World Health Organization's European office said Saturday that more monkeypox-related deaths can be expected, following reports of the first fatalities outside Africa, while stressing that severe complications were still be rare.

WHO expects more monkeypox-related deaths in Europe
A woman waits for a dose of the Monkeypox vaccine in Paris on July 27th. The World Health Organisation said it expects more deaths in Europe due to the virus after two fatal cases were reported in Spain. Photo: ALAIN JOCARD / POOL / AFP

“With the continued spread of monkeypox in Europe, we will expect to see more deaths,” Catherine Smallwood, Senior Emergency Officer at WHO Europe, said in a statement.

Smallwood emphasised that the goal needs to be “interrupting transmission quickly in Europe and stopping this outbreak”.

However, Smallwood stressed that in most cases the disease heals itself without the need for treatment.

“The notification of deaths due to monkeypox does not change our assessment of the outbreak in Europe. We know that although self-limiting in most cases, monkeypox can cause severe complications,” Smallwood noted.

The Spanish health ministry recorded a second monkeypox-related death on Saturday, a day after Spain and Brazil reported their first fatalities.

The announcements marked what are thought to be the first deaths linked to the current outbreak outside Africa.

Spanish authorities would not give the specific cause of death for the fatalities pending the outcome of an autopsy, while Brazilian authorities underlined that the man who died had “other serious conditions”.

“The usual reasons patients might require hospital care include help in managing pain, secondary infections, and in a small number of cases the need to manage life-threatening complications such as encephalitis,” Smallwood explained.

According to the WHO, more than 18,000 cases have been detected throughout the world outside of Africa since the beginning of May, with the majority of them in Europe.

The WHO last week declared the monkeypox outbreak a global health emergency.

As cases surge globally, the WHO on Wednesday called on the group currently most affected by the virus — men who have sex with men — to limit their sexual partners.

Early signs of the disease include a high fever, swollen lymph glands and a chickenpox-like rash.

The disease usually heals by itself after two to three weeks, sometimes taking a month.

A smallpox vaccine from Danish drug maker Bavarian Nordic, marketed under the name Jynneos in the United States and Imvanex in Europe, has also been found to protect against monkeypox.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Why Belgians, Italians, Spanish, and Swiss are coming to France for monkeypox vaccine

Hundreds of Europeans have crossed borders for the monkeypox vaccine, sparking calls to address a gaping inequality in access to doses between nations.

Why Belgians, Italians, Spanish, and Swiss are coming to France for monkeypox vaccine

The current outbreak began in Europe in May, when the virus began spreading rapidly outside areas in Africa where it has long been endemic.

The virus, which is rarely fatal but can cause extremely painful lesions, has overwhelmingly affected men who have sex with men, some of whom have sought to swiftly get vaccinated.

However some countries have had much larger and quicker rollouts of the only approved vaccine for monkeypox, a smallpox jab produced by Danish firm Bavarian Nordic and marketed in Europe as Imvanex.

Belgium, for example, has just 3,000 doses, which are only available to LGBT sex workers, men who have sex with men with sexually transmitted infections or HIV, and some rare contact cases.

But neighbouring France has far more doses. While the exact number is unknown, more than 53,000 doses have already been administered in the country.

READ MORE: France opens monkeypox vaccinedrome

During the European summer many Belgians have popped over the border to get a jab.

Pharmacist Virginie Ceyssac said that 30 to 40 percent of those who had been vaccinated at her Aprium pharmacy in the northern French city of Lille were Belgians.

‘Very warm’ welcome

Samy Soussi of the Brussels-based HIV association ExAequo said that “thanks to word of mouth, we knew that it was possible for Belgians to be vaccinated in France”.

ExAequo even contacted Lille’s vaccination centre to organise carpooling for Belgians to attend a jab rollout day on August 6.

“444 Belgians were vaccinated that morning,” Soussi said, adding they were given a “very warm” welcome.

Around 90 percent of those vaccinated on the day were from Belgium, Lille’s town hall told AFP.

The Hauts-de-France region’s health agency said that its vaccination centres are asked to “respond favourably to requests from Belgian border residents, provided that it does not affect access to vaccinations for the French”.

In France’s capital, vaccinations have also been available for people from outside the country.

“Foreign tourists have taken advantage of their trip to get vaccinated,” said Checkpoint Paris, a sexual health centre dedicated to LGBT people.

However on France’s southern borders, Italians and Spaniards have been very much in the minority for vaccinations, according to local HIV organisations.

Switzerland meanwhile has had zero vaccine doses of its own, though the government bowed to growing criticism by announcing on Wednesday that it would buy 100,000 doses.

Lacking any local doses, “some people have gone to France to get vaccinated without any problems, but others have been refused,” said Alexandra Calmy, head of the HIV unit at Geneva University Hospitals.

Thomas, a 32-year-old in the Swiss town of Montreux, told AFP he spent a fortnight trying to get a vaccination appointment in France.

He eventually managed get an appointment in the eastern French city of Besancon.

“I’ve taken a day off work, I’m going to rent a car and drive,” he said.

‘Expensive and unfair’

A vaccination centre in the French Alpine town of Chambery in the Savoie department refused to give him an appointment.

“We only take people who live in Savoie,” local doctor Silvere Biavat told AFP.

The centre has been “overwhelmed with calls from Swiss people” and has had to turn them away due to a lack of resources, he added.

The French health ministry’s DGS directorate said it was up to vaccination sites whether they administer doses to foreigners.

After being denied an appointment in France, Sergio, a 41-year-old who lives in Geneva, looked farther afield. First he tried in his native Portugal, then in the United States, before finally getting an appointment in London.

“I paid almost 600 euros for a last-minute flight from Geneva to London,” he said.

“It’s expensive and it’s unfair because not everyone can do this… but everyone is afraid” of monkeypox, he said.

The inequality in access has spurred organisations and healthcare professionals across Europe to call for new diplomatic agreements for doses to be shared with countries in need.

“It is not logical that countries like France, Germany and the Netherlands have a great number of the vaccines” while countries like Spain — one of the world’s worst-hit countries — only has 17,000 doses, said Toni Poveda, director of the Spanish HIV organisation CESIDA.

Marc Dixneuf, head of French group AIDES, said that “epidemics don’t pay much attention to borders”.

“What we want is a concerted response at the European level, within the World Health Organization and not just European Union — because we have to include Switzerland,” he said.

French health authorities said they are in contact with Belgium and Switzerland to discuss cross-border monkeypox vaccinations, including financing.

SHOW COMMENTS